Cargando…
VX680 suppresses the growth of HepG2 cells and enhances the chemosensitivity to cisplatin
VX680 is an Aurora A inhibitor. It has been reported to inhibit the growth of the HepG2 cell line in several studies. However, whether it enhances chemosensitivity to cisplatin remains unclear. In this study, the synergistic effect of VX680 and cisplatin on the proliferation of HepG2 cells was deter...
Autores principales: | YAO, RUCHENG, ZHENG, JUN, ZHENG, WEIHONG, GONG, YUAN, LIU, WEI, XING, RONGCHUN |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
D.A. Spandidos
2014
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3861569/ https://www.ncbi.nlm.nih.gov/pubmed/24348832 http://dx.doi.org/10.3892/ol.2013.1648 |
Ejemplares similares
-
Crystal Structure of Human
Aurora B in Complex with
INCENP and VX-680
por: Elkins, Jonathan M., et al.
Publicado: (2012) -
The Effect of Circumscribed Exposure to the Pan-Aurora Kinase Inhibitor VX-680 on Proliferating Euploid Cells
por: Liu, Xumei, et al.
Publicado: (2022) -
Cisplatin-resistant HepG2 cell-derived exosomes transfer cisplatin resistance to cisplatin-sensitive cells in HCC
por: Tang, Zuxiong, et al.
Publicado: (2021) -
Effects of dihydroartemisinin combined with cisplatin on proliferation, apoptosis and migration of HepG2 cells
por: Rao, Qi, et al.
Publicado: (2022) -
Matrix Metalloproteinase 2 Knockdown Suppresses the Proliferation of HepG2 and Huh7 Cells and Enhances the Cisplatin Effect
por: Liu, Jiangwei, et al.
Publicado: (2019)